BlackRock Japan’s Rigel Pharmaceuticals RIGL Stock Holding History

BlackRock Japan’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$11K	Hold	475	–	–	﹤0.01%	1209
2016 Q3	$17K	Sell	475 -91	-16%	-$2.61K	﹤0.01%	1145
2016 Q2	$13K	Sell	566 -176	-24%	-$4.38K	﹤0.01%	1243
2016 Q1	$15K	Buy	742 +241	+48%	+$5.95K	﹤0.01%	1227
2015 Q4	$15K	Sell	501 -199	-28%	-$6.03K	﹤0.01%	1208
2015 Q3	$17K	Buy	700 +51	+8%	+$1.52K	﹤0.01%	1110
2015 Q2	$21K	Buy	+649	New	+$24.8K	﹤0.01%	1194
2015 Q1	–	Sell	-1,620	Closed	-$37K	–	1364
2014 Q4	$37K	Sell	1,620 -139	-8%	-$2.81K	﹤0.01%	1143
2014 Q3	$34K	Hold	1,759	–	–	﹤0.01%	1104
2014 Q2	$64K	Buy	1,759 +255	+17%	+$8.67K	﹤0.01%	1004
2014 Q1	$58K	Buy	+1,504	New	+$53.6K	﹤0.01%	1140
2013 Q3	–	Sell	-1,722	Closed	-$58K	–	1371
2013 Q2	$58K	Buy	+1,722	New	+$78K	﹤0.01%	1067

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BlackRock Japan's RIGL Position: Q4 2016 in Review

BlackRock Japan held its Rigel Pharmaceuticals (RIGL) position steady in Q4 2016 at 475 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

BlackRock Japan first reported a position in RIGL in Q2 2013 and has held it in 12 quarters since. The position peaked at $64K in Q2 2014. 107 funds tracked by Wall St. Rank hold RIGL as of Q4 2016.

BlackRock Japan held 475 shares of Rigel Pharmaceuticals worth $11K as of Q4 2016.
BlackRock Japan left its Rigel Pharmaceuticals share count unchanged in Q4 2016.
Rigel Pharmaceuticals made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1209 holding.
BlackRock Japan first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
BlackRock Japan's Rigel Pharmaceuticals position peaked at $64K in Q2 2014.
107 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.